We show that dystrophic mdx mice exhibit cardiac hypertrophy and that the pharmacological inhibition of the RANKL/RANK interaction prevented the worsening of cardiac hypertrophy and upregulated SERCA activity and expression in dystrophic mdx mice. Here, TNFRSF11A is linked to cardiac hypertrophy.